前列腺癌是男性最常见的泌尿生殖系统恶性肿瘤,去势治疗是其主要的初期治疗手段,但其中大部分患者的肿瘤仍会复发、转移及进展成为去势抵抗性前列腺癌.肿瘤分子生物学研究揭示了较多前列腺癌发生及进展相关的易感基因、抑瘤基因和癌基因及其变异,为优化前列腺癌的预防、诊断和治疗策略提供了依据.%Prostate cancer is the most prevalent male urogenital malignancy.Androgen deprivation therapy is the principal method for initial treatment for the patients,but the majority of them will eventually develop progressive disease,a status called castration-resistant prostate carcinoma.Lots of susceptibility genes,tumor suppressor genes and oncogenes,and their variations rdevant to the occurrence and development of prostate cancer have been revealed by the studies of molecular oncology.These findings on the molecular basis of prostate carcinogenesis will further improve the strategies on prevention,diagnosis and clinical management for prostate carcinoma.
展开▼